WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Exit Postmarket & security

THE TAPE

Comments close on FDA's generative AI device framework Solventum clears its Restrata matrix for use under V.A.C. negative pressure therapy Medtronic takes a CE mark for five conduction system pacing pacemakers Paradromics hands Siemens Healthineers the imaging workup for its brain implant Empyrean submits a 510(k) for Vektra, its robotic brachytherapy system Masimo clears AFib detection on the Radius VSM wearable monitor Sequel clears the twiist insulin pump for adults with type 2 diabetes FTC issues a second request on the MiMedx purchase of Sanara MedTech Labcorp pays $722M upfront for BioReference testing assets Comments close on FDA's generative AI device framework Solventum clears its Restrata matrix for use under V.A.C. negative pressure therapy Medtronic takes a CE mark for five conduction system pacing pacemakers Paradromics hands Siemens Healthineers the imaging workup for its brain implant Empyrean submits a 510(k) for Vektra, its robotic brachytherapy system Masimo clears AFib detection on the Radius VSM wearable monitor Sequel clears the twiist insulin pump for adults with type 2 diabetes FTC issues a second request on the MiMedx purchase of Sanara MedTech Labcorp pays $722M upfront for BioReference testing assets

Extension

Nami Surgical raises £3.4M for a miniature ultrasonic scalpel built for surgical robots

MedDevice Startups Staff · Oct 14 · 2 min read · Via Scottish Enterprise announcement

Nami Surgical said on October 14 that it raised £3.4M, structured as an extension to its earlier round. The Scottish National Investment Bank led the extension with £2M. Existing backers Eos Advisory, Scottish Enterprise and the Investment Fund for Scotland, managed by Maven Capital Partners and delivered through the British Business Bank, joined without disclosing their shares.

The company, a 2021 University of Glasgow spinout founded by Nico Fenu and Rebecca Cleary, builds a miniaturized ultrasonic scalpel. A smaller transducer lets the instrument bend and rotate inside a robotic system while still cutting tissue and sealing vessels. Nami holds ISO 13485 and has no market clearance yet. The money pays for commercialization, R&D hiring and five jobs at its Hillington site in southwest Glasgow. An energy instrument sized for a wristed robotic arm is a component sale, and the list of buyers who need one is short.

Questions & Answers

How much did Nami Surgical raise in October 2026?

Nami Surgical announced £3.4M on October 14, 2026, structured as an extension to its earlier round. The Scottish National Investment Bank contributed £2M of that total.

What does Nami Surgical make?

Nami Surgical builds a miniaturized, patent protected ultrasonic scalpel for robotic assisted surgery. A smaller transducer lets the instrument bend and rotate inside a robotic system while cutting tissue and sealing blood vessels.

Is the Nami Surgical scalpel cleared for sale?

No. As of October 2026 Nami Surgical holds ISO 13485 certification but has announced no market clearance or approval. The company says it is still working toward commercialization and generating adoption evidence.

← Back to Fundraising